1. Home
  2. ATAI vs RIV Comparison

ATAI vs RIV Comparison

Compare ATAI & RIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATAI
  • RIV
  • Stock Information
  • Founded
  • ATAI 2018
  • RIV 2015
  • Country
  • ATAI Germany
  • RIV United States
  • Employees
  • ATAI N/A
  • RIV N/A
  • Industry
  • ATAI Biotechnology: Pharmaceutical Preparations
  • RIV Finance Companies
  • Sector
  • ATAI Health Care
  • RIV Finance
  • Exchange
  • ATAI Nasdaq
  • RIV Nasdaq
  • Market Cap
  • ATAI 271.6M
  • RIV 264.7M
  • IPO Year
  • ATAI 2021
  • RIV N/A
  • Fundamental
  • Price
  • ATAI $1.45
  • RIV $11.81
  • Analyst Decision
  • ATAI Strong Buy
  • RIV
  • Analyst Count
  • ATAI 4
  • RIV 0
  • Target Price
  • ATAI $9.00
  • RIV N/A
  • AVG Volume (30 Days)
  • ATAI 2.1M
  • RIV 87.6K
  • Earning Date
  • ATAI 03-17-2025
  • RIV 01-01-0001
  • Dividend Yield
  • ATAI N/A
  • RIV 12.85%
  • EPS Growth
  • ATAI N/A
  • RIV N/A
  • EPS
  • ATAI N/A
  • RIV N/A
  • Revenue
  • ATAI $308,000.00
  • RIV N/A
  • Revenue This Year
  • ATAI N/A
  • RIV N/A
  • Revenue Next Year
  • ATAI $20.00
  • RIV N/A
  • P/E Ratio
  • ATAI N/A
  • RIV N/A
  • Revenue Growth
  • ATAI N/A
  • RIV N/A
  • 52 Week Low
  • ATAI $0.78
  • RIV $9.63
  • 52 Week High
  • ATAI $2.85
  • RIV $12.43
  • Technical
  • Relative Strength Index (RSI)
  • ATAI 43.24
  • RIV 39.12
  • Support Level
  • ATAI $1.33
  • RIV $11.64
  • Resistance Level
  • ATAI $1.48
  • RIV $11.76
  • Average True Range (ATR)
  • ATAI 0.11
  • RIV 0.17
  • MACD
  • ATAI -0.01
  • RIV -0.03
  • Stochastic Oscillator
  • ATAI 43.41
  • RIV 22.36

About ATAI ATAI Life Sciences N.V.

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.

About RIV RiverNorth Opportunities Fund Inc.

Rivernorth Opportunities Fund Inc is a diversified, closed-end management investment company. The fund's investment objective is total return consisting of capital appreciation and current income.

Share on Social Networks: